

Welcome! Here you will find press releases from LipoScience, health news updates as they relate to new studies published in medical journals, as well as personal and inspirational stories. Whether you're interested in scientific data or a mother's triumph over heart disease, LipoScience and NMR technology are at the core of the story.
We will be updating the site every few weeks, so we hope you will continue to visit. If you are interested in an interview with a scientist or a physician who uses LDL-P by NMR, we are happy to help. We can also provide graphics and video.
For more information, or to request a press kit, please email inquiries@liposcience.com. We are delighted to have this opportunity to work with you!
Click on the links below to view the press releases.
03/11/2013 - New Data Further Links Lipoprotein Particles to Cardiovascular Disease Risk
03/7/2013 - LipoScience to Present at Barclays Global Healthcare Conference
01/25/2013 - LipoScience Prices Initial Public Offering
09/05/2012 - LipoScience receives FDA clearance for Vantera Clinical Analyzer
07/12/2012 - Clinical data finds strong association between HDL particles and coronary heart disease
01/05/2012 - LipoScience submits FDA 510(K) for Vantera® Clinical Analyzer
06/09/2011 - LipoScience launches new website for the NMR LipoProfile test—The Particle Test
06/01/2011 - LipoScience surpasses six million NMR LipoProfile tests ordered
02/28/2011 - LipoScience appoints Thomas Clement Vice President of Regulatory and Quality Affairs
02/21/2011 - LipoScience to present at CED Biotech/Life Science Conference
12/14/2010 - LipoScience presented at the 22nd Annual Piper Jaffrey Health Care Conference
12/06/2010 - LipoScience welcomes Daniel J. Levangie to Board of Directors
09/08/2010 - LipoScience to Present at Multiple Healthcare Conferences in September 2010
09/01/2010 - LipoScience to Present at Robert Baird and Co Healthcare Conference
08/02/2010 - LipoScience to Present at Canaccord Genuity 30th Annual Growth Conference
05/10/2010 - Simple Blood Test May Predict Who Might Develop Type 2 Diabetes among Healthy Women
02/25/2010 - LipoScience to Present at Cowan and Company 30th Annual Health Care Conference
02/05/2010 - LipoScience to Present at 2010 UBS Global Healthcare Services Conference
To request a press kit, please send an email to inquiries@liposcience.com, or call
1-877-547-6837.
LipoScience, Inc. is a highly innovative, diagnostic company focused on changing the way heart disease, diabetes and other metabolic diseases are assessed and managed. We develop proprietary tests based on Nuclear Magnetic Resonance (NMR), an information-rich technology that produces a digital representation of the molecules present in a simple blood sample. Over 5 million NMR LipoProfile® tests have been ordered by physicians. This test directly measures lipoprotein particles and provides physicians and their patients more information to manage their risk for heart disease and diabetes. The company is preparing to decentralize its proprietary platform with a broad array of high value NMR based assays, in support of driving toward new clinical standards of care. We have broad opportunities for growth, and we are actively pursuing those opportunities with the support of our employees, our customers, and our industry partners.
The information provided and claims/statements made by the individuals in the written articles and videos are the sole and exclusive opinion of those individuals and were neither expressed at the request of LipoScience nor necessarily representative of LipoScience’s formal position.
NMR LipoProfile test results can be used with clinical evaluation to aid in the management of lipoprotein disorders associated with cardiovascular disease.
Click on the links below for stories about health news updates, personal and inspirational stories, and new studies published in medical journals.
Medical News Today
Endocrine Today
Diabetes Health
AOL
Forbes
Reuters
Dr. Koop
Fox
WBTV
Dr. Archie Roberts in the Star Journal
In the Battle of the Bulge, medical technology offers smart new weapons!
Childhood Obesity may be Metabolic Syndrome, not Lack of Self Control or Overeating
"Metabolic syndrome is a cluster of risk factors that represents a pre-diabetic state. Although it's hard to say which comes first; the genetic predisposition to metabolic syndrome or the weight gain, they go hand-in-hand. The good news is that the syndrome can be identified and there are sound ways to deal with the condition."
Read firefighter Jeff Ellis' dramatic story and learn how his LDL-P by NMR results helped him and his doctor reduce his risk of heart disease.
" ...cholesterol, like most aspects of human physiology, is more complex than it appears at first blush. Lower cholesterol doesn't always mean you're in the clear for heart disease or stroke. But it's a good place to start."
Reprinted with permission from FireRescue magazine
The information provided and claims/statements made by the individuals in the written articles and videos are the sole and exclusive opinion of those individuals and were neither expressed at the request of LipoScience nor necessarily representative of LipoScience’s formal position.
NMR LipoProfile test results can be used with clinical evaluation to aid in the management of lipoprotein disorders associated with cardiovascular disease.